Literature DB >> 12692286

Functional L polymerase of La Crosse virus allows in vivo reconstitution of recombinant nucleocapsids.

Gjon Blakqori1, Georg Kochs1, Otto Haller1, Friedemann Weber1.   

Abstract

La Crosse virus (LACV), a member of the family Bunyaviridae, is the primary cause of paediatric encephalitis in the United States. In this study, a functional RNA polymerase (L) gene of LACV was cloned and a reverse genetics system established. A reporter minireplicon mimicking the viral genome was constructed by flanking the Renilla luciferase gene with the 3' and 5' noncoding regions of the genomic M segment. These noncoding regions serve as promoters for the viral polymerase. Both L and nucleocapsid (N) genes were expressed by means of T7 RNA polymerase, which was provided by the recombinant T7-expressing modified vaccinia virus Ankara. Renilla reporter activity in transfected cells reflected reconstitution of recombinant nucleocapsids by functional L and N gene products. Time-course experiments revealed a rapid increase in minireplicon activity from 10 to 18 h after the onset of L and N expression. Minireplicon activity was found to be dependent on the correct ratio of L to N plasmids, with too much of either construct resulting in downregulation. Furthermore, a specific inhibitory effect of LACV NSs protein on minireplicon activity was found. In passaging experiments using parental helper virions, it was demonstrated that the recombinant nucleocapsids are a useful model for transcription, replication and packaging of LACV.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692286     DOI: 10.1099/vir.0.18876-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  35 in total

1.  Signatures of host mRNA 5' terminus for efficient hantavirus cap snatching.

Authors:  Erdong Cheng; Mohammad A Mir
Journal:  J Virol       Date:  2012-07-11       Impact factor: 5.103

2.  Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II.

Authors:  Paul Verbruggen; Marius Ruf; Gjon Blakqori; Anna K Överby; Martin Heidemann; Dirk Eick; Friedemann Weber
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

3.  Mechanism of tripartite RNA genome packaging in Rift Valley fever virus.

Authors:  Kaori Terasaki; Shin Murakami; Kumari G Lokugamage; Shinji Makino
Journal:  Proc Natl Acad Sci U S A       Date:  2010-12-27       Impact factor: 11.205

4.  Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system.

Authors:  Tetsuro Ikegami; C J Peters; Shinji Makino
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

5.  Homotypic interaction of Bunyamwera virus nucleocapsid protein.

Authors:  Vincent H J Leonard; Alain Kohl; Jane C Osborne; Angela McLees; Richard M Elliott
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

6.  Characterization of the RNA chaperone activity of hantavirus nucleocapsid protein.

Authors:  M A Mir; A T Panganiban
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

7.  Hantavirus N protein exhibits genus-specific recognition of the viral RNA panhandle.

Authors:  M A Mir; B Brown; B Hjelle; W A Duran; A T Panganiban
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

8.  Hantavirus nucleocapsid protein has distinct m7G cap- and RNA-binding sites.

Authors:  Mohammad A Mir; Sheema Sheema; Abdul Haseeb; Absarul Haque
Journal:  J Biol Chem       Date:  2010-02-17       Impact factor: 5.157

9.  Ribosomal protein S19-binding domain provides insights into hantavirus nucleocapsid protein-mediated translation initiation mechanism.

Authors:  Safder S Ganaie; Absarul Haque; Erdong Cheng; Tania S Bonny; Nilshad N Salim; Mohammad A Mir
Journal:  Biochem J       Date:  2014-11-15       Impact factor: 3.857

10.  Molecular biology of rift valley Fever virus.

Authors:  Michele Bouloy; Friedemann Weber
Journal:  Open Virol J       Date:  2010-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.